−5.72 USD
−9.21 M USD
731.49 K USD
1.22 M
About Mangoceuticals, Inc.
Sector
CEO
Jacob D. Cohen
Headquarters
Dallas
Website
Founded
2021
FIGI
BBG01CCMR9Q3
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MGRX is 4.25 USD — it has increased by 24.27% in the past 24 hours. Watch Mangoceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mangoceuticals, Inc. stocks are traded under the ticker MGRX.
MGRX stock has risen by 51.79% compared to the previous week, the month change is a 56.25% rise, over the last year Mangoceuticals, Inc. has showed a −27.33% decrease.
MGRX reached its all-time high on Mar 21, 2023 with the price of 65.55 USD, and its all-time low was 2.07 USD and was reached on Dec 30, 2024. View more price dynamics on MGRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MGRX stock is 27.22% volatile and has beta coefficient of −0.84. Track Mangoceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Mangoceuticals, Inc. there?
Today Mangoceuticals, Inc. has the market capitalization of 8.50 M, it has increased by 9.12% over the last week.
Yes, you can track Mangoceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
MGRX net income for the last quarter is −2.00 M USD, while the quarter before that showed −2.39 M USD of net income which accounts for 16.38% change. Track more Mangoceuticals, Inc. financial stats to get the full picture.
No, MGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 8, 2025, the company has 3.00 employees. See our rating of the largest employees — is Mangoceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mangoceuticals, Inc. EBITDA is −8.80 M USD, and current EBITDA margin is −1.26 K%. See more stats in Mangoceuticals, Inc. financial statements.
Like other stocks, MGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mangoceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mangoceuticals, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mangoceuticals, Inc. stock shows the buy signal. See more of Mangoceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.